Abstract
Background: Overt hypothyroidism has been found to be associated with cardiovascular disease. Moreover, subclinical hypothyroidism is a strong indicator of risk for aortic atherosclerosis and myocardial infarction.
Hypothesis: We hypothesized that variation of thyroid function within the normal range may influence the presence and severity of coronary atherosclerosis.
Methods: We studied a total of 100 consecutive men and women (59 men, 41 women, age 63.7 ± 11.0 years) who underwent coronary angiography. Blood was tested for serum thyrotropin concentrations and for free tri‐iodothyronine and free thyroxine concentrations. In addition to the assessment of thyroid function, conventional risk factors for coronary artery disease (CAD), clinical characteristics, serum lipid levels, fasting total homocysteine, and angiographic results of coronary artery assessment were obtained. Two experienced cardiologists blinded to clinical and laboratory data reviewed the cine‐films. The severity of CAD was scored as 0 for those with smooth normal epicardial coronary arteries, 0.5 for plaquing (< 50% diameter stenosis), and 1,2, or 3 for those with single‐, double‐, or triple‐vessel epicardial coronary artery stenosis of > 50%, respectively.
Results: The severity of CAD was scored as 0,0.5,1,2, and 3 in 14,26,25,22, and 13 patients, respectively. Higher levels of serum‐free thyroid hormone concentrations were associated with decreased severity of coronary atherosclerosis. Serum‐free tri‐iodothyronine was 2.99 ±0.33 pg/ml in patients with a CAD severity score of 0 to 1 and 2.74 ± 0.49 pg/ml in patients with CAD severity scores of 2 and 3 (p <0.01). Moreover, serum‐free thyroxine concentrations showed a trend toward higher levels in patients with CAD severity score 0 to 1 compared with patients with CAD severity scores 2 and 3 (11.65 ± 1.87 pg/ml vs. 10.9 ± 2.3 pg/ml; p = 0.09). Higher levels of serum thyrotropin concentrations were associated with increased severity of coronary atherosclerosis (1.37 ± 1.02 mU/l vs. 1.98 ± 2.13 mU/l in patients with CAD severity score 0 to 1 versus CAD severity scores 2 and 3; p=0.049). When grouped into three subsets according to their serum free tri‐iodothyronine levels (<2.79, 2.8 to 3.09, and ± 3.1 pg/ml), the prevalence of CAD scores 2 and 3 was significantly higher in the subset of patients with low serum free tri‐iodothyronine levels (48.5%) than in the subsets of patients with medium or high tri‐iodothyronine concentrations (32.25 and 25%, respectively, p for trend < 0.05).
Conclusion: These data in patients referred for coronary angiography suggest that variation of thyroid function within the statistical normal range may influence the presence and severity of coronary atherosclerosis.
Keywords: thyroid function, thyrotropin, coronary artery disease, hypothyroidism, hyperthyroidism
Full Text
The Full Text of this article is available as a PDF (51.4 KB).
References
- 1. Gomberg‐Maitland M, Frishman WH: Thyroid hormone and cardiovascular disease. Am Heart J 1998; 135: 187–196 [DOI] [PubMed] [Google Scholar]
- 2. Auer J, ScheibnerP, MischeT , Langsteger W, Eber O, Eber B: Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J 2002; 142: 838–842 [DOI] [PubMed] [Google Scholar]
- 3. Klein I, Ojamaa K: Thyroid hormone and the cardiovascular system. NEngl J Med 2001; 344: 501–509 [DOI] [PubMed] [Google Scholar]
- 4. Klein I, Ojamaa K: Thyroid hormone and the heart. Am J Med 1996; 101: 459–160 [DOI] [PubMed] [Google Scholar]
- 5. Klein I, Ojamaa K: The cardiovascular system in hypothyroidism In Werner and Ingbar's The Thyroid, 7th ed. (Eds. Braverman LE, Utiger RD.), p. 799–804. Philadelphia: Lippincott‐Raven, 1996. [Google Scholar]
- 6. Steinberg AD: Myxedema and coronary artery disease‐a comparative autopsy study. Ann Intern Med 1968; 68: 338–344 [DOI] [PubMed] [Google Scholar]
- 7. Hak AE, Pols HAP, Visser TJ, Drexhage HA, Hofman A, Witteman JCM: Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam study. Ann Intern Med 2000; 132: 270–278 [DOI] [PubMed] [Google Scholar]
- 8. Harjai KJ, Licata AA: Effects of amiodarone on thyroid function. Ann Intern Med 1997; 126: 63–73 [DOI] [PubMed] [Google Scholar]
- 9. World Health Organization. Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation on Obesity, Geneva, 3‐5 June, 1997. Geneva: World Health Organization, 1998. [PubMed] [Google Scholar]
- 10. Judkins MF: Selective coronary arteriography: A percutaneous transfemoral technique. Radiology 1967; 89: 815–824 [DOI] [PubMed] [Google Scholar]
- 11. Abell LL, Levy BB, Brodie BB, Kendall FE: A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 1952; 195: 357–366 [PubMed] [Google Scholar]
- 12. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA: Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol (Oxf) 1977; 7: 495–508 [DOI] [PubMed] [Google Scholar]
- 13. Tièche M, Lupi GA, Gutzwiller F, Grob PJ, Studer H, Burgi H: Borderline low thyroid function and thyroid autoimmunity. Risk factors for coronary heart disease? Br Heart J 1981; 46: 202–206 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Dean JW, Fowler PB: Exaggerated responsiveness to thyrotrophin releasing hormone: A risk factor in women with coronary artery disease. Br Med J 1985; 290: 1555–1561 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Powell J, Zadeh JA, Carter G, Greenhalgh RM, Fowler PB: Raised serum thyrotrophin in women with peripheral arterial disease. Br J Surg 1987; 74: 1139–1141 [DOI] [PubMed] [Google Scholar]
- 16. Heinonen OP, Gordin A, Aho K, Punsar S, Pyorala K, Puro K: Symptomless autoimmune thyroiditis in coronary heart‐disease. Lancet 1972; 1: 785–786 [DOI] [PubMed] [Google Scholar]
- 17. Pop VJ, Kuijpens JL, van Baar AL, Verkerk G, van Son MM, de Vijlder JJ, Vulsma T, Wiersinga WM, Drexhage HA, Vader HL: Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf) 1999; 50: 149–155 [DOI] [PubMed] [Google Scholar]
- 18. Saravanan P, Chau W‐F, Roberts N, Vedhara K, Dayan CM: Psychological well‐being in patients on “adequate” doses of L‐thyroxine: Results of a large controlled community based questionnaire study. Clin Endocrinol (Oxf) 2002; 57: 577–585 [DOI] [PubMed] [Google Scholar]
- 19. Michalopoulou G, Alevizaki M, Piperingos G, Mitsibounas D, Mantzos E, Adamopoulos P, Koutras DA: High serum cholesterol levels in persons with “high‐normal” TSH levels: Should one extend the definition of subclinical hypothyroidism? Eur J Endocrinol 1998; 138: 141–145 [DOI] [PubMed] [Google Scholar]
- 20. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ: Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 1999; 340: 424–429 [DOI] [PubMed] [Google Scholar]
- 21. Andersen S, Pedersen KM, Bruun NH, Laurberg P: Narrow individual variations in serum T4 and T3 in normal subjects: A clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 2002; 87: 1068–1072 [DOI] [PubMed] [Google Scholar]
- 22. Dayan CM, Saravanan P, Bayly G: Whose normal thyroid function is better‐yours or mine? Lancet 2002; 360: 353–354 [DOI] [PubMed] [Google Scholar]
- 23. Ishikawa T, Chijiwa T, Hagiwara M, Mamiya S, Hidaka H: Thyroid hormones directly interact with muscular smooth muscle strips. Mol Pharmacol 1989; 35: 760–765 [PubMed] [Google Scholar]
- 24. Chadarevian R, Bruckert E, Ankri A, Beucler I, Giral P, Turpin G: Relationship between thyroid hormones and plasma D‐dimer levels. Thromb Haemost 1998; 79: 99–103 [PubMed] [Google Scholar]
- 25. Koltringer P, Eber O, Wakonig P, Klima G, Lind P: Hypothyroidism and the influence on human blood rheology. J Endocrinol Invest 1988; 11: 267–272 [DOI] [PubMed] [Google Scholar]
- 26. Mamiya S, Hagiwara M, Inoue S, Hidaka H: Thyroid hormones inhibit platelet function and myosin light chain kinase. J Biol Chem 1989; 264: 8575–8579 [PubMed] [Google Scholar]
- 27. Luboshitzky R, Aviv A, Herer P, Lavie L: Risk factors for cardiovascular disease in women with subclinical [DOI] [PubMed]